Biotechnology
Breaking News
Healthcare
Investing News
Market News
Technology
The Buzz
The Buzz TV
The Market Buzz
Top Videos
Video
“The Buzz” Show: Addex Pharmaceuticals (NASDAQ: ADXN) Terminates Dipraglurant Phase 2b/3 Study
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Addex Pharmaceuticals Terminates Dipraglurant Phase 2b/3 Study” Addex Therapeutics Ltd (NASDAQ: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...